Visualization and quantification of disease progression in multiple system atrophy

被引：0
|
作者：
Hauser, Till K.
Lufi, Andreas R.
Skalej, Martin
Nägele, Thomas
Kircher, Tilo T.
Leube, Dirk T.
Schulz, Jörg B.
机构：
来源：
ANNALS OF NEUROLOGY | 2006年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [21] Is Multiple System Atrophy an Infectious Disease?
    Wenning, Gregor
    Trojanowski, John Q.
    Kaufmann, Horacio
    Wisniewski, Thomas
    Rocca, Walter A.
    Low, Phillip A.
    ANNALS OF NEUROLOGY, 2018, 83 (01) : 10 - 12
  • [22] MRI Morphometry in Early Multiple System Atrophy: Correlations with Indices of Disease Burden & Tracking Progression
    Vemuri, Prashanthi
    Castillo, Anna
    Thostenson, Kaely
    Ward, Chadwick
    Reddy, Ashritha
    Gehrking, Tonette
    Gehrking, Jade
    Zeller, Anita
    Jack, Clifford
    Low, Phillip
    Singer, Wolfgang
    NEUROLOGY, 2019, 92 (15)
  • [23] Quantification of pyramidal tract Pathology in multiple system atrophy (MSA)
    Schuepbach, Michael
    Z'Graggen, Werner
    Kaelin-Lang, Alain
    Roesler, Kai M.
    NEUROLOGY, 2007, 68 (12) : A50 - A50
  • [24] Serum lipid levels are associated with the prevalence but not with the disease progression of multiple system atrophy in a Chinese population
    Cao, Bei
    Guo, XiaoYan
    Chen, Ke
    Song, Wei
    Huang, Rui
    Wei, Qian-Qian
    Zhao, Bi
    Shang, Hui-Fang
    NEUROLOGICAL RESEARCH, 2014, 36 (02) : 150 - 156
  • [25] Disease Progression in Multiple System Atrophy: The Value of Clinical Cohorts with Long Follow-Up
    Saulnier, Tiphaine
    Fabbri, Margherita
    Pavy-Le Traon, Anne
    Le Goff, Melanie
    Helmer, Catherine
    Peran, Patrice
    Meissner, Wassilios G.
    Rascol, Olivier
    Foubert-Samier, Alexandra
    Proust-Lima, Cecile
    MOVEMENT DISORDERS, 2023, 38 (08) : 1567 - 1569
  • [26] Natural History and Disease Progression Biomarkers of Multiple System Atrophy: The ASPIRE-MSA Study
    Del Campo, N.
    Peran, P.
    Payoux, P.
    Rousseau, V.
    Drif, A.
    Catala, H.
    Thalamas, C.
    Tranchant, C.
    Duriff, F.
    Marques, A.
    Azulay, J. P.
    Moreau, C.
    Corvol, J. C.
    Thobois, S.
    Corbille, A. G.
    Frismand, S.
    Patterson, B.
    Foubert-Samier, A.
    Pavy-Letraon, A.
    Fabbri, M.
    Meissner, W.
    Rascol, O.
    MOVEMENT DISORDERS, 2023, 38 : S68 - S69
  • [27] Disease Progression In Multiple System Atrophy: The Value Of Clinical Cohorts With Long Follow-Up
    Saulnier, T.
    Fabbri, M.
    Pavy-Le Traon, A.
    Le Goff, M.
    Helmer, C.
    Peran, P.
    Meissner, W. G.
    Rascol, O.
    Proust-Lima, C.
    Foubert-Samier, A.
    MOVEMENT DISORDERS, 2023, 38 : S74 - S74
  • [28] Subcortical nuclei atrophy in multiple sclerosis: depending on disease progression
    Ilves, A.
    Prakhova, L.
    Kataeva, G.
    Totolyan, N.
    Pozdnyakov, A.
    Scoromets, A.
    Stolyarov, I.
    MULTIPLE SCLEROSIS, 2007, 13 : S177 - S177
  • [29] Progression of cardinal symptoms and MRI findings in multiple system atrophy
    Murata, M.
    Ogawa, M.
    MOVEMENT DISORDERS, 2010, 25 (07) : S504 - S505
  • [30] Blood NfL Can Track Progression In Multiple System Atrophy
    Chelban, V.
    Perez-Soriano, A.
    Wilke, C.
    Foubert-Samier, A.
    Vijiaratnam, N.
    Guo, T.
    Jabbari, E.
    Senkevich, K.
    Laurens, B.
    Peran, P.
    Rascol, O.
    Schols, L.
    Kobylecki, C.
    Hu, M.
    Rowe, J.
    Foltynie, T.
    Wood, N.
    Heslegrave, A.
    Zetterberg, H.
    Bocchetta, M.
    Rohrer, J.
    Marti, M.
    Synofzik, M.
    Morris, H.
    Meissner, W.
    Houlden, H.
    MOVEMENT DISORDERS, 2023, 38 : S66 - S67
12345